Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy

Pancreatic cancer is one of the most lethal tumor types worldwide and an effective therapy is still elusive. Targeted therapy focused against a specific alteration is by definition unable to attack broad pathway signaling modification. Tumor heterogeneity will render targeted therapies ineffective b...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Kristin, Lademann, Franziska, Thepkaysone, May-Linn, Jahnke, Beatrix, Aust, Daniela E., Kahlert, Christoph, Weber, Georg, Weitz, Jürgen, Grützmann, Robert, Pilarsky, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826184/
https://www.ncbi.nlm.nih.gov/pubmed/26716649
http://dx.doi.org/10.18632/oncotarget.6766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826184/
https://www.ncbi.nlm.nih.gov/pubmed/26716649
http://dx.doi.org/10.18632/oncotarget.6766

Ejemplares similares